The Patent Finder
US

Isoindolinone Compounds

US 12,391,663 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jan 13, 2042 · High confidence

Filed Oct 27, 2023 as application 18/496,504 · Granted Aug 19, 2025
Base term, 20 years from filing
Today
20 years from filing
2022 2042
Clock starts
Jan 13, 2022
Term ends
Jan 13, 2042
Granted
Aug 19, 2025
base term Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,912,682, to Jan 13, 2042. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 13, 2022, when application PCT/EP2022/050699, the earliest non-provisional in its chain, was filed (this one was filed Oct 27, 2023)Jan 13, 2042High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 11,912,682)resolves to Jan 13, 2042, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 13, 2042High confidence

Partial family

Application PCT/EP2022/050699PCT application
no patent term
no patent term
US 11,912,682In force
Jan 2042
Jan 2042
US 12,391,663this patent
Jan 2042
Jan 2042
Application 19/236,429Pending
not computed
not computed
Partial: 1 of the 4 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 13, 2025
Reel 70211, frame 247
Fasching, Bernhard; Ryckmans, Thomas; Flohr, Alexander; Ritzén, Andreas; Harvey, Freya; McAllister, LauraMonte Rosa Therapeutics AGAssignment of Assignor's Interest
Feb 13, 2025
Reel 70211, frame 300
Monte Rosa Therapeutics AGMonte Rosa Therapeutics, Inc.Assignment of Assignor's Interest
Feb 21, 2025
Reel 70287, frame 504
Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics AGAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited